Updated efficacy and safety of melflufen in patients with relapsed/refractory multiple myeloma refractory to daratumumab and/or pomalidomide: HORIZON (OP-106) Meeting Abstract
| Authors: | Richardson, P. G.; Oriol, A.; Larocca, A.; Rodriguez-Otero, P.; Norkin, M.; Blade, J.; Cavo, M.; Hassoun, H.; Leleu, X.; Alegre, A.; Maisel, C.; Paner, A.; Mazumder, A.; Zonder, J. A.; Puig, N.; Harran, J.; Harmenberg, J.; Thuresson, S.; Zubair, H.; Mateos, M. V. |
| Abstract Title: | Updated efficacy and safety of melflufen in patients with relapsed/refractory multiple myeloma refractory to daratumumab and/or pomalidomide: HORIZON (OP-106) |
| Meeting Title: | 2019 Lymphoma and Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 94 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Oct 23-26 |
| Meeting Location: | New York, NY |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2019-11-01 |
| Start Page: | S24 |
| End Page: | S25 |
| Language: | English |
| ACCESSION: | WOS:000491489200036 |
| PROVIDER: | wos |
| PUBMED: | 31621937 |
| DOI: | 10.1002/ajh.25639 |
| Notes: | Meeting Abstract: P-035 -- Source: Wos |
